Asher Salmon
Impact in
- Neurology top 5%
- Neuroblastoma Research and Treatments
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 7
-
- Neuroendocrine Tumor Research Advances 6
- Co-authors
- David J. Gross (10 shared papers)Merav Fraenkel (4 shared papers)Benjamin Gläser (3 shared papers)Victoria Doviner (2 shared papers)Hermona Soreq (2 shared papers)Zafrir Goren (1 shared paper)Roy Eldor (1 shared paper)Yodphat Krausz (3 shared papers)
In The Last Decade
Asher Salmon
29 papers receiving 753 citations
Peers
Comparison fields: 5 of 90
- Neurology 171
- Cancer Research 134
- Oncology 226
- Epidemiology 260
- Toxicology 28
Countries citing papers authored by Asher Salmon
This map shows the geographic impact of Asher Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher Salmon more than expected).
Fields of papers citing papers by Asher Salmon
This network shows the impact of papers produced by Asher Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher Salmon. The network helps show where Asher Salmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Asher Salmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 121 | |
| 2 | 2010 | 109 | |
| 3 | 2011 | 84 | |
| 4 | 1999 | 65 | |
| 5 | 2010 | 52 | |
| 6 | 2013 | 40 | |
| 7 | 2011 | 32 | |
| 8 | 2020 | 31 | |
| 9 | 2005 | 28 | |
| 10 | 2014 | 22 | |
| 11 | 2012 | 21 | |
| 12 | 2018 | 19 | |
| 13 | 2005 | 19 | |
| 14 | 2021 | 19 | |
| 15 | 2015 | 17 | |
| 16 | 2020 | 16 | |
| 17 | 2018 | 14 | |
| 18 | 2017 | 14 | |
| 19 | 2015 | 10 | |
| 20 | 2007 | 9 |
About Asher Salmon
Asher Salmon is a scholar working on Oncology, Epidemiology, Molecular Biology, Genetics and Cancer Research, having authored 29 papers that have together received 772 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (6 papers), BRCA gene mutations in cancer (5 papers), Adrenal and Paraganglionic Tumors (4 papers), Breast Cancer Treatment Studies (3 papers), Pituitary Gland Disorders and Treatments (3 papers), DNA Repair Mechanisms (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Neurology (171 citations), Cancer Research (134 citations), Oncology (226 citations), Epidemiology (260 citations) and Toxicology (28 citations). Asher Salmon has collaborated with scholars based in Israel, Belgium and Australia. Frequent co-authors include David J. Gross, Merav Fraenkel, Benjamin Gläser, Victoria Doviner, Hermona Soreq, Zafrir Goren, Roy Eldor, Yodphat Krausz, Nanette Freedman and Sagi Tshori. Their work appears in journals such as Clinical Endocrinology, Molecular Imaging and Biology, Biochemical and Biophysical Research Communications, Oncotarget and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.